Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 10.6% in the morning session after Piper Sandler ...

Myriad Genetics (NASDAQ:MYGN) traded higher on Wednesday after Piper Sandler upgraded the cancer test developer to Overweight ...

Fintel reports that on March 12, 2025, Piper Sandler upgraded their outlook for Myriad Genetics (NasdaqGS:MYGN) from Neutral ...

A large genome-wide association study meta-analysis analyzed data on 42 female reproductive health diagnoses from the ...

Ensuring every newborn has access to life-saving screening and treatment is both a moral and economic imperative.' ...

A new study from Oxford Population Health has revealed that lifestyle choices and environmental factors have a much bigger ...

Stay up to date on the work of researchers in NYU Langone’s Center for Human Genetics and Genomics by reading the latest news ...

It seems like no matter what I do, I can't lose weight. Most of my family members struggle with their weight too. Do our ...

Assessing productivity in a beef herd can be done using a range of different metrics. In many cases producers focus on some ...

Two studies led by researchers at the Broad Institute of MIT and Harvard and Mass General Brigham have greatly expanded the ...

Fulgent Genetics exceeded expectations in the fourth quarter of 2024, showcasing robust revenue growth and a GAAP loss.